As part of our ongoing commitment to driving dermatology research forward, SCARLETRED’s CEO Dr. Harald Schnidar will give an invited talk at the Department of Clinical Pharmacology, Medical University of Vienna.

The lecture, titled "From Academia to Industry: Innovating AI and SaaS Business in Skin Drug R&D," will be held on Tuesday at 14:00 in the Seminar Room 06.L1.08 as part of the university’s official continuing education program (Fortbildungsserie) for Vienna General Hospital (AKH).

Dr. Schnidar will share insights into the successful translation of academic research into real-world applications, focusing on how AI-powered platforms like Scarletred®Vision are transforming clinical dermatology trials, accelerating skin drug development, and creating new standards in digital health.

Our strong clinical research collaboration with the Department of Clinical Pharmacology underpins these advancements, further strengthening the bridge between academic excellence and industrial innovation.

We are proud to contribute to the next generation of clinical research and digital healthcare innovation, and to continue pushing the boundaries in skin drug development.

Together, we drive dermatology research forward!